Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
445.9 USD | +0.15% | +3.71% | +9.58% |
15/05 | Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director | CI |
14/05 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.58% | 11TCr | |
+12.41% | 11TCr | |
-2.59% | 2.2TCr | |
-12.38% | 2.19TCr | |
-5.29% | 1.92TCr | |
-3.35% | 1.81TCr | |
-38.57% | 1.77TCr | |
+7.51% | 1.43TCr | |
+35.67% | 1.24TCr | |
-24.50% | 823.19Cr |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 08